Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RISEDRONIC ACID Cause Intentional product use issue? 75 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Intentional product use issue have been filed in association with RISEDRONIC ACID. This represents 16.3% of all adverse event reports for RISEDRONIC ACID.

75
Reports of Intentional product use issue with RISEDRONIC ACID
16.3%
of all RISEDRONIC ACID reports
7
Deaths
69
Hospitalizations

How Dangerous Is Intentional product use issue From RISEDRONIC ACID?

Of the 75 reports, 7 (9.3%) resulted in death, 69 (92.0%) required hospitalization, and 13 (17.3%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RISEDRONIC ACID. However, 75 reports have been filed with the FAERS database.

What Other Side Effects Does RISEDRONIC ACID Cause?

Drug ineffective (127) Nausea (106) Off label use (95) Infection (89) Rheumatoid arthritis (89) Diarrhoea (84) Drug hypersensitivity (83) Mobility decreased (82) Pulmonary fibrosis (79) Loss of consciousness (78)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which RISEDRONIC ACID Alternatives Have Lower Intentional product use issue Risk?

RISEDRONIC ACID vs RISPERDAL RISEDRONIC ACID vs RISPERDAL CONSTA RISEDRONIC ACID vs RISPERIDONE RISEDRONIC ACID vs RITALIN RISEDRONIC ACID vs RITLECITINIB

Related Pages

RISEDRONIC ACID Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue RISEDRONIC ACID Demographics